Michigan SB 483: Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.

Status: referred to Committee on Insurance and Financial Services (as of 2023-10-04)

State: Michigan · Session: 2023-2024 · Bill: SB 483

Subjects: Health: pharmaceuticals, State agencies (existing): boards and commissions, State agencies (existing): insurance and financial services

Sponsors: Darrin Camilleri, Dayna Polehanki, Erika Geiss, Jeff Irwin, Jeremy Moss, John Cherry, Kristen McDonald Rivet, Mallory McMorrow, Mary Cavanagh, Paul Wojno, Rosemary Bayer, Sam Singh, Sarah Anthony, Stephanie Chang, Sue Shink, Sylvia A. Santana, Veronica Klinefelt, Winnie Brinks

View Michigan SB 483 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.